Author:
Nassarmadji Kladoum,Vanjak Anthony,Bourdin Venceslas,Champion Karine,Burlacu Ruxandra,Mouly Stéphane,Sène Damien,Comarmond Cloé
Abstract
Diagnosis, prognostic assessment, and monitoring disease activity in patients with large vessel vasculitis (LVV) can be challenging. Early recognition of LVV and treatment adaptation is essential because vascular complications (aneurysm, dilatations, ischemic complications) or treatment related side effects can occur frequently in these patients. 18-fluorodeoxyglucose positron emission tomography/computed tomography (2-[18F]FDG-PET/CT) is increasingly used to diagnose, follow, and evaluate treatment response in LVV. In this review, we aimed to summarize the current evidence on the value of 2-[18F]FDG-PET/CT for diagnosis, follow, and treatment monitoring in LVV.
Reference87 articles.
1. 2012 Revised international chapel hill consensus conference nomenclature of vasculitides.;Jennette;Arthritis Rheum.,2013
2. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.;Dejaco;Ann Rheum Dis.,2018
3. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography.;Kubota;J Nucl Med.,1992
4. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.;Yamada;J Nucl Med.,1995
5. Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany.;Reinhold-Keller;Rheumatol Oxf Engl.,2000
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献